Chinese english Germany Japanese Korea

2-(2-(4-((1s,3s)-adamantane-1-carbonyl)piperazin-1-yl)ethyl)-1H-benzo[de]isoquinoline-1,3(2H)-dione

2-(2-(4-((1s,3s)-adamantane-1-carbonyl)piperazin-1-yl)ethyl)-1H-benzo[de]isoquinoline-1,3(2H)-dione Struktur
326889-50-3
CAS-Nr.
326889-50-3
Englisch Name:
2-(2-(4-((1s,3s)-adamantane-1-carbonyl)piperazin-1-yl)ethyl)-1H-benzo[de]isoquinoline-1,3(2H)-dione
Synonyma:
2-(2-(4-((1s,3s)-adamantane-1-carbonyl)piperazin-1-yl)ethyl)-1H-benzo[de]isoquinoline-1,3(2H)-dione;1H-Benz[de]isoquinoline-1,3(2H)-dione, 2-[2-[4-(tricyclo[3.3.1.13,7]dec-1-ylcarbonyl)-1-piperazinyl]ethyl]-
CBNumber:
CB33838508
Summenformel:
C29H33N3O3
Molgewicht:
471.59
MOL-Datei:
326889-50-3.mol
Request For Quotation

2-(2-(4-((1s,3s)-adamantane-1-carbonyl)piperazin-1-yl)ethyl)-1H-benzo[de]isoquinoline-1,3(2H)-dione Eigenschaften

Siedepunkt:
676.3±50.0 °C(Predicted)
Dichte
1.308±0.06 g/cm3(Predicted)
pka
6.43±0.10(Predicted)

Sicherheit

2-(2-(4-((1s,3s)-adamantane-1-carbonyl)piperazin-1-yl)ethyl)-1H-benzo[de]isoquinoline-1,3(2H)-dione Chemische Eigenschaften,Einsatz,Produktion Methoden

2-(2-(4-((1s,3s)-adamantane-1-carbonyl)piperazin-1-yl)ethyl)-1H-benzo[de]isoquinoline-1,3(2H)-dione Upstream-Materialien And Downstream Produkte

Upstream-Materialien

Downstream Produkte

2-(2-(4-((1s,3s)-adamantane-1-carbonyl)piperazin-1-yl)ethyl)-1H-benzo[de]isoquinoline-1,3(2H)-dione Anbieter Lieferant Produzent Hersteller Vertrieb Händler.

Global( 4)Lieferanten
Firmenname Telefon E-Mail Land Produktkatalog Edge Rate
Specs --
 info@specs.net The Netherlands 6835 70
LIFE CHEMICALS, formerly I.F. Lab --
 vasily.pinchuk@lifechemicals.com Canada 6706 69
PHARMEKS Ltd. --
 sales@pharmeks.com Finland 6350 50
Interbioscreen Ltd. --
 screen@ibscreen.chg.ru Finland 6178 60
  • 2-(2-(4-((1s,3s)-adamantane-1-carbonyl)piperazin-1-yl)ethyl)-1H-benzo[de]isoquinoline-1,3(2H)-dione
  • 1H-Benz[de]isoquinoline-1,3(2H)-dione, 2-[2-[4-(tricyclo[3.3.1.13,7]dec-1-ylcarbonyl)-1-piperazinyl]ethyl]-
  • 326889-50-3
Copyright 2019 © ChemicalBook. All rights reserved